Skip to main content

Table 2 Apoptosis rates of tumor tissue in different treatment groups

From: Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma

Groups

Bax/GAPDH

Caspase-3/GAPDH

Bcl-2/GAPDH

Control

0.105 ± 0.001

0.055 ± 0.002

0.529 ± 0.002

MTD NVB

0.443 ± 0.002

0.168 ± 0.001

0.380 ± 0.001

Endo+MTD NVB

0.698 ± 0.003**

0.514 ± 0.002**

0.148 ± 0.001**

Endo

0.068 ± 0.001

0.036 ± 0.001

0.694 ± 0.003

MET NVB

0.571 ± 0.002

0.359 ± 0.001

0.375 ± 0.001

Endo+MET NVB

0.748 ± 0.003**

0.602 ± 0.003**

0.061 ± 0.001**

  1. Data are presented as the mean ± SD. *P < 0.05, **P < 0.01 versus the control group; #P < 0.05, ##P < 0.01 versus the MET NVB+ Endo group
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us